Welcome to our dedicated page for Novanta SEC filings (Ticker: NOVT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Novanta Inc. (Nasdaq: NOVT) files a range of documents with the U.S. Securities and Exchange Commission that shed light on its operations as a global supplier of core technology solutions for medical, life science, and advanced industrial OEMs. This SEC filings page brings together those disclosures so investors can review the company’s regulatory record in one place.
Among the most frequently referenced filings are current reports on Form 8-K, where Novanta announces quarterly financial results, provides non-GAAP metrics such as Adjusted EBITDA and Adjusted Diluted EPS, and discloses material events. Recent 8-K filings have covered results for specific fiscal quarters, revisions to financial guidance, changes in Board composition, and details of share repurchase authorizations.
Filings also document capital markets and financing transactions, including the underwriting agreement and terms of Novanta’s tangible equity units offering, which combines prepaid stock purchase contracts with senior amortizing notes due 2028. Related 8-Ks describe settlement mechanics, interest and installment payments, and the listing of the units under the symbol NOVTU. Other filings outline the terms of the company’s senior credit facilities under its Fourth Amended and Restated Credit Agreement and subsequent amendments, including leverage and coverage covenants.
Through this page, users can access Novanta’s 10-K annual reports and 10-Q quarterly reports (when filed), as well as Forms 4 and other ownership-related filings, via real-time updates from EDGAR. AI-powered summaries help explain complex sections, highlight key changes from prior periods, and clarify the implications of items such as guidance revisions, credit agreement provisions, and share repurchase programs.
Whether reviewing earnings-related disclosures, tracking capital structure developments, or examining governance and compensation information, this filings hub provides a structured entry point into Novanta’s SEC reporting history.
Novanta Inc. Co-Chief Operating Officer Charles Guy Ravetto, Jr. reported transactions related to restricted stock units and common shares. On February 24, he exercised 825 restricted stock units into 825 common shares at no cost, then disposed of 243 common shares at
Novanta Inc. chief accounting officer John Joseph Burke II reported routine equity award activity. He exercised 479 Restricted Stock Units, each converting into one common share, and received 479 common shares at a stated price of
On the same date, Burke disposed of 141 common shares at
Novanta Inc.’s Chief Financial Officer Robert Buckley reported equity compensation activity involving performance stock units and common stock. On February 24, 2026, he exercised 5,426 Performance Stock Units, receiving the same number of Novanta common shares at a price of $0.00 per share.
On the same date, 2,624 common shares were disposed of at $137.44 per share to satisfy tax withholding obligations related to the award. After these transactions, Buckley directly held 96,616 common shares. He also reported 36,219 common shares held indirectly through the Buckley Family Irrevocable Trust.
Novanta Inc. director and CEO Matthijs Glastra reported equity award activity involving company stock. On
On the same date, 5,247 shares of common stock were disposed of at
Novanta Inc. Chief Accounting Officer John Joseph Burke II reported vesting of 519 Restricted Stock Units on
Novanta Inc.'s Co-Chief Operating Officer Charles Guy Ravetto Jr. reported equity compensation activity involving restricted stock units and common shares. On February 23, 2026, he exercised 1,059 restricted stock units, converting them into 1,059 common shares at a stated price of $0.00 per share. A separate transaction shows 311 common shares disposed of at $142.38 per share to satisfy tax withholding obligations, a common non-market transaction. After these movements, his directly held common stock position was 15,534 shares. Footnotes explain that each restricted stock unit represents one Novanta common share and that the units vest in three equal installments on February 21, 2025, February 23, 2026 and February 22, 2027, reflecting a multi-year vesting schedule.
Novanta Inc. Chief Accounting Officer John Joseph Burke II reported several equity award transactions involving company stock on February 20, 2026. He received a grant of 1,062 Restricted Stock Units (RSUs), each convertible into one common share upon vesting. He also exercised 490 RSUs into 490 common shares at no cash exercise price, increasing his directly held common stock to 8,389 shares before a related tax transaction. To cover tax obligations, 170 common shares were disposed of at $145.96 per share, leaving him with 8,219 common shares held directly. The newly granted RSUs vest in three equal installments on February 20 of 2027, 2028, and 2029, while another RSU award vests in three equal installments on February 20 of 2026, 2027, and 2028.
Novanta Inc.’s Chief Financial Officer Robert Buckley reported multiple equity transactions on common stock and equity awards. He received a grant of 11,990 Restricted Stock Units, each convertible into one common share upon vesting in three equal installments on February 20 of 2027, 2028, and 2029.
He also exercised derivative awards into common stock, including Restricted Stock Units and stock options that had previously vested, and had 93,814 common shares held directly afterward. To cover taxes, 1,185 shares were disposed of at about $145.96 per share, and additional open-market sales totaling 1,423 shares occurred around $140–$144 per share under a pre-established Rule 10b5-1 trading plan. Buckley also reported 36,219 common shares held indirectly through the Buckley Family Irrevocable Trust.
Novanta Inc. Chief Executive Officer Matthijs Glastra reported multiple equity transactions involving company stock on February 20, 2026. He received a grant of 26,035 Restricted Stock Units (RSUs), each representing one Novanta common share upon vesting. On the same date, he exercised 5,322 RSUs, converting them into 5,322 shares of common stock, and disposed of 2,574 common shares to satisfy tax obligations at a price of $145.96 per share. After these transactions, he directly owned 64,156 common shares and 10,645 RSUs, and indirectly held 54,382 common shares through the Matthijs Glastra 2021 Irrevocable Trust. The new RSU grant vests in three equal installments on February 20, 2027, February 20, 2028, and February 20, 2029.
Novanta Inc. Co-Chief Operating Officer Charles Guy Ravetto Jr. reported equity award and related share transactions on February 20, 2026. He acquired 1,633 common shares through the exercise of Restricted Stock Units and received a new grant of 7,537 Restricted Stock Units.
After the RSU conversion, his direct common stock holdings were 15,266 shares, before a 480-share tax-withholding disposition at $145.96 per share reduced that balance to 14,786 shares. Following the transactions, he also directly holds 3,269 previously awarded Restricted Stock Units and a new award of 7,537 Restricted Stock Units, each representing one common share upon vesting over scheduled dates from 2026 through 2029.